Korro Bio expects to soon initiate a phase 1/2 study, using KRRO-110 for the treatment of patients with Alpha-1 Antitrypsin Deficiency, with data to be released 2nd half of 2024. Interim analysis from ...

insights from industryJack O'Meara Co-Founder and CEOOchre-Bio In this interview, we speak with Jack O'Meara, co-founder and CEO of Ochre Bio, a pioneering force in liver disease treatment. O'Meara ...

Over the past few years, the excitement over genome editing has moved well beyond the original CRISPR-Cas system described a decade ago, into areas such as the discovery of new Cas systems, CRISPR ...

RNA is a fundamental molecule of life that plays diverse structural, functional, and regulatory roles in all organisms and pathogenic viruses. In recent years, the discovery of new classes of RNA ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Exai Bio today announced new data demonstrating that its novel RNA-based and AI-driven liquid biopsy platform can detect breast cancer at the earliest stages and ...

Analyst Kostas Biliouris from BMO Capital maintained a Buy rating on Korro Bio (KRRO – Research Report) and keeping the price target at $120.00. Kostas Biliouris has given his Buy rating due to a ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of the ddSEQ™ Single-Cell 3' RNA-Seq Kit and ...

Using a novel method, Weizmann Institute of Science researchers map 16 types of simultaneous changes in dozens of samples; ...

Scientists successfully extract RNA from a 130-year-old Tasmanian tiger, thylacine, revealing how its genes functioned before its extinction.

When a gene is expressed, its DNA sequence is transcribed into a molecule known as RNA. Then the cell processes and edits that RNA before it is translated into protein. Many genes can be processed and ...

The scale of technology exports by domestic pharmaceutical and bio-pharmaceutical companies has exceeded 20 trillion won this ...